Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis - PubMed (original) (raw)
Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis
Ian Ford et al. PLoS Med. 2009.
Abstract
Background: Reduced glomerular filtration rate (GFR) is associated with increased cardiovascular risk in young and middle aged individuals. Associations with cardiovascular disease and mortality in older people are less clearly established. We aimed to determine the predictive value of the GFR for mortality and morbidity using data from the 5,804 participants randomized in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Methods and findings: Glomerular filtration rate was estimated (eGFR) using the Modification of Diet in Renal Disease equation and was categorized in the ranges ([20-40], [40-50], [50-60]) >or= 60 ml/min/1.73 m(2). Baseline risk factors were analysed by category of eGFR, with and without adjustment for other risk factors. The associations between baseline eGFR and morbidity and mortality outcomes, accrued after an average of 3.2 y, were investigated using Cox proportional hazard models adjusting for traditional risk factors. We tested for evidence of an interaction between the benefit of statin treatment and baseline eGFR status. Age, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, C-reactive protein (CRP), body mass index, fasting glucose, female sex, histories of hypertension and vascular disease were associated with eGFR (p = 0.001 or less) after adjustment for other risk factors. Low eGFR was independently associated with risk of all cause mortality, vascular mortality, and other noncancer mortality and with fatal and nonfatal coronary and heart failure events (hazard ratios adjusted for CRP and other risk factors (95% confidence intervals [CIs]) for eGFR < 40 ml/min/1.73m(2) relative to eGFR >or= 60 ml/min/1.73m(2) respectively 2.04 (1.48-2.80), 2.37 (1.53-3.67), 3.52 (1.78-6.96), 1.64 (1.18-2.27), 3.31 (2.03-5.41). There were no nominally statistically significant interactions (p < 0.05) between randomized treatment allocation and eGFR for clinical outcomes, with the exception of the outcome of coronary heart disease death or nonfatal myocardial infarction (p = 0.021), with the interaction suggesting increased benefit of statin treatment in subjects with impaired GFRs.
Conclusions: We have established that, in an elderly population over the age of 70 y, impaired GFR is associated with female sex, with presence of vascular disease, and with levels of other risk factors that would be associated with increased risk of vascular disease. Further, impaired GFR is independently associated with significant levels of increased risk of all cause mortality and fatal vascular events and with composite fatal and nonfatal coronary and heart failure outcomes. Our analyses of the benefits of statin treatment in relation to baseline GFR suggest that there is no reason to exclude elderly patients with impaired renal function from treatment with a statin.
Conflict of interest statement
Competing Interests: JS reports that he was a consultant to Pfizer in the Treating to New Targets study and that he has been a speaker's bureau member for AstraZeneca and Pfizer.
Similar articles
- C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J; PROSPER Study Group. Sattar N, et al. Circulation. 2007 Feb 27;115(8):981-9. doi: 10.1161/CIRCULATIONAHA.106.643114. Epub 2007 Feb 5. Circulation. 2007. PMID: 17283264 Clinical Trial. - Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaboration; Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C. Cholesterol Treatment Trialists' (CTT) Collaboration, et al. Lancet Diabetes Endocrinol. 2016 Oct;4(10):829-39. doi: 10.1016/S2213-8587(16)30156-5. Epub 2016 Jul 29. Lancet Diabetes Endocrinol. 2016. PMID: 27477773 - Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.
Rahman M, Baimbridge C, Davis BR, Barzilay JI, Basile JN, Henriquez MA, Huml A, Kopyt N, Louis GT, Pressel SL, Rosendorff C, Sastrasinh S, Stanford C; ALLHAT Collaborative Research Group. Rahman M, et al. Clin Nephrol. 2013 Oct;80(4):235-48. doi: 10.5414/CN107922. Clin Nephrol. 2013. PMID: 23816477 Free PMC article. Clinical Trial. - Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M. Tonelli M, et al. Circulation. 2004 Sep 21;110(12):1557-63. doi: 10.1161/01.CIR.0000143892.84582.60. Epub 2004 Sep 13. Circulation. 2004. PMID: 15364796 Review. - Low glomerular filtration rate and risk of stroke: meta-analysis.
Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Lee M, et al. BMJ. 2010 Sep 30;341:c4249. doi: 10.1136/bmj.c4249. BMJ. 2010. PMID: 20884696 Free PMC article. Review.
Cited by
- Comprehensive proteomics of monocytes indicates oxidative imbalance functionally related to inflammatory response in chronic kidney disease-related atherosclerosis.
Watral J, Formanowicz D, Perek B, Kostka-Jeziorny K, Podkowińska A, Tykarski A, Luczak M. Watral J, et al. Front Mol Biosci. 2024 Feb 8;11:1229648. doi: 10.3389/fmolb.2024.1229648. eCollection 2024. Front Mol Biosci. 2024. PMID: 38389898 Free PMC article. - Trunk muscle quality and quantity are associated with renal volume in nondiabetic people.
Tanaka M, Okada H, Hashimoto Y, Kumagai M, Yamaoka M, Nishimura H, Fukui M. Tanaka M, et al. Clin Kidney J. 2023 Aug 25;16(12):2597-2604. doi: 10.1093/ckj/sfad202. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38046018 Free PMC article. - Cystatin C-based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study.
Liao J, Xiao F, Yang L, Wei Y, Song C, Li J, Yu S, Lu Y, Zhang J, Dai L, Liang W, Li T, Xiong Z, Wu Y, Jardine MJ, Carrero JJ, Shan Y, Huang X. Liao J, et al. Clin Kidney J. 2023 Aug 9;16(11):2059-2071. doi: 10.1093/ckj/sfad188. eCollection 2023 Nov. Clin Kidney J. 2023. PMID: 37915909 Free PMC article. - Association of pre-ESRD care education with patient outcomes in a 10-year longitudinal study of patients with CKD stages 3-5 in Taiwan.
Chou CL, Chung CH, Chiu HW, Liao CT, Wu CC, Hsu YH, Chien WC. Chou CL, et al. Sci Rep. 2021 Nov 19;11(1):22602. doi: 10.1038/s41598-021-01860-9. Sci Rep. 2021. PMID: 34799610 Free PMC article.
References
- Shadman R, Allison MA, Criqui MH. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients. J Am Coll Cardiol. 2007;49:2172–2181. - PubMed
- Abaci A, Sen N, Yazici H, Tulmac M, Turkoglu S, et al. Renal dysfunction is the most important predictor of the extent and severity of coronary artery disease in patients with diabetes mellitus. Coron Artery Dis. 2007;18:463–469. - PubMed
- Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13:599–608. - PubMed
- Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail. 2007;13:422–430. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous